Access cutting-edge bladder carcinoma treatment through this clinical trial at a research site in Greeley. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Greeley location
Preparing your pre-screening questions…
Access bladder carcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder carcinoma treatment provided free
Check if you qualify for this bladder carcinoma clinical trial in Greeley, CO
No-Cost Study Care
Local to Greeley
Convenient for CO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a need to understand how MCDs may work as cancer screening tools. The goal of cancer screening is to reduce the burden of cancer by identifying cancers before they show symptoms or signs, when treatment is likely to be most effective. In this study, adults aged 45-75 without cancer will be randomly assigned to one of 3 groups: 2 separate MCD test groups or a control group. These two MCD tests will not be compared to each other but will be compared to cancers detected in the control group. This study will provide early information on how well MCD tests perform as cancer screening tools. It will also help researchers understand how patients and their doctors make decisions about their care when the MCD test result comes back as normal (negative) or abnormal (positive).
Sponsor: National Cancer Institute (NCI)
Yes, this clinical trial (NCT06995898) has an active research site in Greeley, CO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for bladder carcinoma treatment options in Greeley, CO, this clinical trial (NCT06995898) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Greeley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all bladder carcinoma clinical trials near you to find additional studies recruiting in your area.
See all bladder cancer clinical trials recruiting in Greeley — not just this study.
Browse Bladder Cancer Trials in Greeley →